Top Success Tips From Experienced About Brain Hemorrhage

1
Brain Hemorrhage - Pipeline Review H1 2016
Telephone [phone]Mail at
sales_at_researchbeam.com
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
Published on Oct 2014
2


Report Overview

• Brain Hemorrhage - Pipeline Review, H1 2016,
  provides an overview of the Brain Hemorrhage
  pipeline landscape.
• This report provides comprehensive information on
  the therapeutics under development for Brain
  Hemorrhage, complete with analysis by stage of
  development, drug target, mechanism of action
  (MoA), route of administration (RoA) and molecule
  type. The report also covers the descriptive
  pharmacological action of the therapeutics, its
  complete research and development history and
  latest news and press releases. Additionally, the
  report provides an overview of key players
  involved in therapeutic development for Brain
  Hemorrhage and features dormant and discontinued
  projects.
• Global Markets Directs report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, company/university
  websites, clinical trial registries, conferences,
  SEC filings, investor presentations and featured
  press releases from company/university sites and
  industry-specific third party sources. Drug
  profiles featured in the report undergoes
  periodic review following a stringent set of
  processes to ensure that all the profiles are
  updated with the latest set of information.
  Additionally, various dynamic tracking processes
  ensure that the most recent developments are
  captured on a real time basis.
• This report helps in identifying and tracking
  emerging players in the market and their
  portfolios, enhances decision making capabilities
  and helps to create effective counter strategies
  to gain competitive advantage.
• Strategic Focus Report _at_ http//www.researchbeam.c
  om/brain-hemorrhage-pipeline-review-h1-2016-market

3


Report Overview

• Scope
• - The report reviews pipeline therapeutics for
  Brain Hemorrhage by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• - The report covers pipeline products based on
  various stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• - The report features descriptive drug profiles
  for the pipeline products which includes, product
  description, descriptive MoA, RD brief,
  licensing and collaboration details other
  developmental activities
• - The report reviews key players involved Brain
  Hemorrhage therapeutics and enlists all their
  major and minor projects
• Reasons to buy
• - Gain strategically significant competitor
  information, analysis, and insights to formulate
  effective RD strategies
• - Identify emerging players with potentially
  strong product portfolio and create effective
  counter-strategies to gain competitive advantage
• - Identify and understand important and diverse
  types of therapeutics under development for Brain
  Hemorrhage
• - Plan mergers and acquisitions effectively by
  identifying key players and its most promising
  pipeline therapeutics

4


Table of Contents
Table of Contents 2 List of Tables 4 List of
Figures 4 Introduction 5 Global Markets Direct
Report Coverage 5 Brain Hemorrhage Overview
6 Therapeutics Development 7 Pipeline Products
for Brain Hemorrhage - Overview 7 Brain
Hemorrhage - Therapeutics under Development by
Companies 8 Brain Hemorrhage - Pipeline Products
Glance 9 Late Stage Products 9 Clinical Stage
Products 10 Early Stage Products 11 Brain
Hemorrhage - Products under Development by
Companies 12 Brain Hemorrhage - Companies
Involved in Therapeutics Development 13 Edge
Therapeutics, Inc. 13 F. Hoffmann-La Roche Ltd.
14 Fina Biotech 15 MediPost Co., Ltd. 16 Pfizer
Inc. 17 Remedy Pharmaceuticals, Inc. 18 Brain
Hemorrhage - Therapeutics Assessment
19 Assessment by Monotherapy Products
19 Assessment by Target 20
5


Table of Contents
Assessment by Mechanism of Action 22 Assessment
by Route of Administration 24 Assessment by
Molecule Type 26 Drug Profiles 28 alteplase -
Drug Profile 28 Product Description 28 Mechanism
of Action 28 RD Progress 28 aprotinin - Drug
Profile 30 Product Description 30 Mechanism of
Action 30 RD Progress 30 CN-105 - Drug Profile
31 Product Description 31 Mechanism of Action
31 RD Progress 31 glyburide - Drug Profile
32 Product Description 32 Mechanism of Action
32 RD Progress 32 PF-05230907 - Drug Profile
35 Product Description 35 Mechanism of Action
35 RD Progress 35
6


Report Ordering
Report Name Brain Hemorrhage -
Pipeline Review H1 2016
Product Price
User Price
Single User US 1700
Site User US 4000
Global User US 6000
To View Sample or Purchase Report
7



Contact Us
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/brain-hemorrhage-pipel
ine-review-h1-2016-market
Stay With Us At
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com